Evaluating the role of pharmacists in providing care with long-acting injectables for HIV and PrEP
Open Access
- 26 May 2026
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (4) , 103149
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan AreaAIDS Patient Care and STDs, 2024
- Pharmacist-Involved Antiretroviral Stewardship Programs in People Living with HIV/AIDS: A Systematic ReviewAIDS Patient Care and STDs, 2023
- Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness studyJournal of the International AIDS Society, 2022
- Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)Journal of the International AIDS Society, 2022
- Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinicPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Medication access: Policy and practice opportunities for pharmacistsJACCP: Journal of the American College of Clinical Pharmacy, 2020
- Identifying appropriate candidates for long-acting antiretroviral therapy: findings from a survey of health care providers in the ATLAS-2M trialHIV Research & Clinical Practice, 2020
- The Pharmacist's Expanding Role in HIV Pre-Exposure ProphylaxisAIDS Patient Care and STDs, 2019
- Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trialHIV Research & Clinical Practice, 2018
- Outcomes of pharmacist-assisted management of antiretroviral therapy in patients with HIV infection: A risk-adjusted analysisAmerican Journal of Health-System Pharmacy, 2015